Pharmacokinetics
Showing 9951 - 9975 of >10,000
Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Endocarditis Trial in Philadelphia (Oritavancin Injection)
Withdrawn
- Staphylococcus Aureus Bacteremia
- Staphylococcus Aureus Endocarditis
- Oritavancin Injection
-
Philadelphia, PennsylvaniaClinical Trials Unit. University of Pennsylvania
Mar 28, 2022
Preeclampsia Trial in Peoria (Aspirin 162 mg)
Recruiting
- Preeclampsia
- Aspirin 162 mg
-
Peoria, IllinoisUnityPoint Clinic Family Medicine
Jan 22, 2022
Breastfeeding Trial in Washington (Diet soda)
Recruiting
- Breastfeeding
- Diet soda
-
Washington, District of ColumbiaThe George Washington University
May 17, 2022
Food Effect, Health Subjects Trial in Shanghai (Volitinib)
Completed
- Food Effect
- Health Subjects
-
Shanghai, Shanghai, ChinaShanghai Xuhui Central Hospital
May 12, 2019
Pharmacokinetics of ASP9853, Non-hematologic Malignancies Trial in Boston, Detroit, Nashville (ASP9853, Docetaxel, Paclitaxel)
Terminated
- Pharmacokinetics of ASP9853
- Non-hematologic Malignancies
- ASP9853
- +2 more
-
Boston, Massachusetts
- +3 more
May 29, 2019
Pain Trial in Nottingham (Nanoformed Piroxicam IR Tablet, Felden (piroxicam) Tablets, Brexidol (piroxicam) Tablets)
Completed
- Pain
- Nanoformed Piroxicam IR Tablet
- +2 more
-
Nottingham, United KingdomQuotient Sciences
Oct 29, 2021
Bioequivalence, Healthy Subjects Trial in Amman (PERINDOPRES® TRIO, 8 mg perindopril tert-butylamine / 2.5 mg indapamide / 10 mg
Completed
- Bioequivalence
- Healthy Subjects
- PERINDOPRES® TRIO, 8 mg perindopril tert-butylamine / 2.5 mg indapamide / 10 mg amlodipine tablets
- TRIPLIXAM® 10 mg /2.5 mg/10 mg, 10 mg perindopril arginine / 2.5 mg indapamide / 10 mg amlodipine film-coated tablets
-
Amman, JordanInternational Pharmaceutical Research Center
Jul 20, 2022
MDD Trial in Dallas (LY2216684, Theophylline)
Completed
- Major Depressive Disorder
-
Dallas, TexasFor additional information regarding investigative sites for thi
Apr 16, 2019
Myelofibrosis Trial in Worldwide (Ruxolitinib, Siremadlin, Crizanlizumab)
Suspended
- Myelofibrosis
- Ruxolitinib
- +5 more
-
Adelaide, South Australia, Australia
- +37 more
Aug 18, 2022
Soft Tissue Sarcoma Trial in Worldwide (Olaratumab, Pembrolizumab)
Active, not recruiting
- Soft Tissue Sarcoma
-
Boston, Massachusetts
- +5 more
Jul 19, 2022
Gastric Cancer, Gastroesophageal-junction Cancer Trial (Tcrx T cell)
Not yet recruiting
- Gastric Cancer
- Gastroesophageal-junction Cancer
- Tcrx T cell
- (no location specified)
Jul 21, 2022
Covid19 Trial in South Africa, United Kingdom (CST-2: EIDD-2801, CST-2: Placebo, Nitazoxanide)
Recruiting
- Covid19
- CST-2: EIDD-2801
- +6 more
-
Cape Town, South Africa
- +5 more
Aug 9, 2022
Pharmacokinetics Trial in Aachen (Tapentadol Test Product 1, Tapentadol Test Product 2, Tapentadol Prolonged-release Reference
Completed
- Pharmacokinetics
- Tapentadol Test Product 1
- +2 more
-
Aachen, GermanyDepartment of Clinical Pharmacology, Grünenthal GmbH
May 17, 2019
Asthma Trial in Gainesville (Fluticasone Propionate Formulation 1, Fluticasone Propionate Formulation 2, Fluticasone Propionate
Completed
- Asthma
- Fluticasone Propionate Formulation 1
- +3 more
-
Gainesville, FloridaUniversity of Florida
Dec 27, 2018
Pharmacokinetics Trial in San Antonio (Proellex)
Completed
- Pharmacokinetics
-
San Antonio, TexasHealthcare Discoveries Inc.
Jan 23, 2019
Healthy Volunteers Trial in San Antonio (Placebo, teduglutide)
Completed
- Healthy Volunteers
- Placebo
- teduglutide
-
San Antonio, TexasCetero Clinical Research
Jun 2, 2021
Pediatric CNS Tumor Trial in United States (tozuleristide, Canvas System)
Completed
- Pediatric Central Nervous System Tumor
- tozuleristide
- Canvas System
-
Los Angeles, California
- +8 more
Nov 9, 2022